Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Total 13F shares
-
22,810,612
-
Share change
-
+1,618,902
-
Total reported value
-
$544,488,456
-
Price per share
-
$23.87
-
Number of holders
-
32
-
Value change
-
+$38,849,002
-
Number of buys
-
15
-
Number of sells
-
11
Institutional Holders of MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) as of Q1 2019
As of 31 Mar 2019,
MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,810,612 shares.
The largest 10 holders included
BB BIOTECH AG, RA CAPITAL MANAGEMENT, LLC, NovaQuest Capital Management, L.L.C., JANUS HENDERSON GROUP PLC, EVENTIDE ASSET MANAGEMENT, LLC, LORD, ABBETT & CO. LLC, VICTORY CAPITAL MANAGEMENT INC, PRICE T ROWE ASSOCIATES INC /MD/, NORGES BANK, and Cormorant Asset Management, LP.
This page lists
32
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.